Pierre Bady - Institute of Social and Preventive Medicine, University of Lausanne

基本信息

Career Trajectory

Bio

consult web site for more details and information: https://badozor.github.io/

Research Interests

Papers共 60 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Clinical Value of the MGMT Promoter Methylation Score in IDHmt Low-Grade Glioma for Predicting Benefit from Temozolomide Treatment

Amelie Darlix,Pierre Bady,Jeremy Deverdun,Karine Lefort,Valerie Rigau,Emmanuelle Le Bars, Justine Meriadec,Mathilde Carriere,Arthur Coget,Thomas Santarius,Tomasz Matys,Hugues Duffau,Monika E. Hegi

NEURO-ONCOLOGY ADVANCESno. 1 (2025)

Cited0Views0WOSBibtex

Supplementary Figure 5 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial

Monika E. Hegi,Annie-Claire Diserens,Pierre Bady,Yuta Kamoshima,Mathilde C. M. Kouwenhoven,Mauro Delorenzi,Wanyu L. Lambiv,Marie-France Hamou, Matthias S. Matter,Arend Koch, Frank L. Heppner,Yasuhiro Yonekawa,Adrian Merlo,Karl Frei,Luigi Mariani, Silvia Hofer

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 3 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial

Monika E. Hegi,Annie-Claire Diserens,Pierre Bady,Yuta Kamoshima,Mathilde C. M. Kouwenhoven,Mauro Delorenzi,Wanyu L. Lambiv,Marie-France Hamou,Matthias S. Matter,Arend Koch,Frank L. Heppner,Yasuhiro Yonekawa,Adrian Merlo,Karl Frei,Luigi Mariani,Silvia Hofer

openalex（2023）

Cited0Views0Bibtex

Supplementary Table 1 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 2 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial

Monika E. Hegi,Annie-Claire Diserens,Pierre Bady,Yuta Kamoshima,Mathilde C. M. Kouwenhoven,Mauro Delorenzi,Wanyu L. Lambiv,Marie-France Hamou,Matthias S. Matter,Arend Koch,Frank L. Heppner,Yasuhiro Yonekawa,Adrian Merlo,Karl Frei,Luigi Mariani,Silvia Hofer

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure 4 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial

openalex（2023）

Cited0Views0Bibtex

Supplementary Methods, Figure Legends 1-5 from Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn